Skip to main content

Advertisement

SpringerLink
Log in

Inflammation and rheumatoid arthritis

  • Mini Review
  • Published:
Journal of Physiology and Biochemistry Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Adam B, John M (2006) Rituximab and its potential for the treatment of rheumatoid arthritis. Ther Clin Risk Manag 2(2):207–212

    Article  Google Scholar 

  2. Aggarwal R, Liao K, Nair R et al (2009) Anti-citrullinated peptide antibody assays and their role in the diagnosis of rheumatoid arthritis. Arthritis Care Res 61(11):1472–1483

    Article  Google Scholar 

  3. Arnett FC, Edworthy SM, Bloch DA et al (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum Mar 31(3):315–324

    Article  CAS  Google Scholar 

  4. Barksby HE, Lea SR, Preshaw PM, Taylor JJ (2007) The expanding family of interleukin-1 cytokines and their role in destructive inflammatory disorders. Clin Exp Immunol 149:217–225

    Article  PubMed  CAS  Google Scholar 

  5. Begic Z, Terzic R, Dinarevic S et al (2004) Prognostic significance of juvenile chronic arthritis onset types. Med Arh 58:163–166

    PubMed  Google Scholar 

  6. Benderdour M, Tardif G, Pelletier JP et al (2002) Interleukin 17 (IL-17) induces collagenase-3 production in human osteoclastic chondrocytes via AP-1 dependent activation: differential activation of AP-1 members by IL-17 and IL-1β β. J Rheum 29:1262–1272

    PubMed  CAS  Google Scholar 

  7. Berglin E, Padyukov L, Sundin U et al (2004) A combination of autoantibodies to cyclic citrullinated peptide (CCP) and HLA-DRB1 locus antigens is strongly associated with future onset of rheumatoid arthritis. Arthritis Res Ther 6:R303–R308

    Article  PubMed  CAS  Google Scholar 

  8. Butler DM, Maini RN, Feldmann M, Brennan FM (1995) Modulation of proinflammatory cytokine release in rheumatoid synovial membrane cell cultures: comparison of monoclonal anti TNF-a antibody with interleukin- 1 receptor antagonist. Eur Cytokine Netw 6:225–230

    PubMed  CAS  Google Scholar 

  9. Camussi G, Albano E, Tetta C, Bussolino F (1991) The molecular action of tumor necrosis factor-alpha. Eur J Biochem 202:3–14

    Article  PubMed  CAS  Google Scholar 

  10. Cassim B, Mody G, Bhoola K (2002) Kallikrein cascades and cytokines in inflamed joints. Pharmacol Ther 94(1–2):1–34

    Article  PubMed  CAS  Google Scholar 

  11. Chabaud M, Lubberts E, Joosten L et al (2001) IL-17 derived from juxta-articular bone and synovium contributes to joint degradation in rheumatoid arthritis. Arthritis Res 3:168–177

    Article  PubMed  CAS  Google Scholar 

  12. Charles AD (2000) Proinflammatory cytokines. Chest 118:503–508

    Article  Google Scholar 

  13. Chikashi T, Koichiro O, Masaki K et al (2011) Myelin basic protein as a novel genetic risk factor in rheumatoid arthritis—a genome-wide study combined with immunological analyses. PLoS One 6(6):e20457

    Article  CAS  Google Scholar 

  14. Cope AP, Schulze-Koops H, Aringer M (2007) The central role of T cells in rheumatoid arthritis. Clin Exp Rheumatol Sep-Oct 25(5 Suppl 46):S4–S11

    CAS  Google Scholar 

  15. Cornelia MW, Jorg JG (2000) Association of MHC and rheumatoid arthritis: HLA polymorphisms in phenotypic variants of rheumatoid arthritis. Arthritis Res 2(3):212–216

    Article  Google Scholar 

  16. Daniel A, Tuhina N, Alan JS et al (2010) 2010 rheumatoid arthritis classification criteria. Arthritis Rheum 62(9):2569–2581

    Article  Google Scholar 

  17. David AF (2000) Cytokine blockade as a new strategy to treat rheumatoid arthritis. Inhibition of tumor necrosis factor. Arch intern med 28:437–444

    Google Scholar 

  18. Dayer JM (2003) The pivotal role of interleukin-1 in the clinical manifestations of rheumatoid arthritis. Rheumatology 42(Suppl. 2):ii3–ii10

    PubMed  CAS  Google Scholar 

  19. Deborah PM (2002) Epidemiology of rheumatoid arthritis: determinants of onset, persistence and outcome. Clin Rheu 111:172–177

    Google Scholar 

  20. Deighton CM, Walker DJ, Griffiths ID, Roberts DF (1989) The contribution of HLA to rheumatoid arthritis. Clin Genet 36:178–182

    Article  PubMed  CAS  Google Scholar 

  21. DeMaria AN (2002) Relative risk of cardiovascular events in patients with rheumatoid arthritis. Am J Cardiol 89(suppl):33–38

    Article  Google Scholar 

  22. Derkjen VZ, Johanna MWH, Aeilko HZ et al (1992) Clinical significance of rheumatoid factors in early rheumatoid arthritis: results of a follow up study. Ann Rheum Dis 51:1029–1035

    Article  Google Scholar 

  23. Dinarello CA (2002) The IL-1 family and inflammatory diseases. Clin Exp Rheumatol 20:S1–S13

    PubMed  CAS  Google Scholar 

  24. Ditoro R, Polito C (1997) Nutrition in juvenile rheumatoid arthritis. Nutr Res 17:741–758

    Article  CAS  Google Scholar 

  25. Edward MV, Paul E (2006) Abatacept in the treatment of rheumatoid arthritis. Herapeutics Clin Risk Manag 2(4):365–375

    Article  Google Scholar 

  26. Feldmann M, Brennan FM, Maini RN (1996) Role of cytokines in rheumatoid arthritis. Annu Rev Immunol 14:397–440

    Article  PubMed  CAS  Google Scholar 

  27. Feuchtenberger M, Kneitz C, Tony HP (2007) Cytokines. Z Rheumatol 66(4):297–298

    Article  PubMed  CAS  Google Scholar 

  28. Fleischmann RM, Tesser J, Schiff MH et al (2006) Safety of extended treatment with Anakinra in patients with rheumatoid arthritis. Ann Rheum Dis 65:1006–1012

    Article  PubMed  CAS  Google Scholar 

  29. Franklin HE, Ernest HSC, Gabriel SP (2001) Cytokine pathways and joint inflammation in rheumatoid arthritis. N Engl J Med 344(12):907–916

    Article  Google Scholar 

  30. Gabay C, Kushner I (1999) Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 340(6):448–454

    Article  PubMed  CAS  Google Scholar 

  31. Gay S, Koopman WJ (1989) Immunopathology of rheumatoid arthritis. Curr Rheumatol 1:8–14

    Article  CAS  Google Scholar 

  32. Harrington L, Hatton R, Mangan P et al (2005) Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol 6:1123–1132

    Article  PubMed  CAS  Google Scholar 

  33. Huber LC, Distler O, Tarner I et al (2006) Synovial fibroblasts: key players in rheumatoid arthritis. Rheumatology 45:669–675

    Article  PubMed  CAS  Google Scholar 

  34. Hwang S, Kim H (2005) Expression of IL-17 homologs and their receptors in the synovial cells of rheumatoid arthritis patients. Mol Cells 19:180–184

    PubMed  CAS  Google Scholar 

  35. Hye JK, Claudia B (2000) B cells in rheumatoid arthritis. Arthritis Res 2:126–131

    Article  Google Scholar 

  36. Iain BM, Bernard PL, Roger DS et al (1997) Interleukin-15 mediates T cell-dependent regulation of tumor necrosis factor-alpha production in rheumatoid arthritis. Nature Med 3(2):189–195

    Article  Google Scholar 

  37. Jabs WJ, Theissing E, Nitschke M et al (2003) Local generation of C-reactive protein in diseased coronary artery venous bypass grafts and normal vascular tissue. Circulation 108:1428–1431

    Article  PubMed  CAS  Google Scholar 

  38. Josef SS, Ravinder NM (2006) Interleukin-6: a new therapeutic target. Arthritis Research & Therapy 8(Suppl 2):S5

    Article  CAS  Google Scholar 

  39. Kay J, Calabrese L (2004) The role of interleukin-1 in the pathogenesis of rheumatoid arthritis. Rheumatology 43(suppl 3):iii2–iii9

    Article  PubMed  Google Scholar 

  40. Kharazmi A, Nielsen H, Rechnitzer C, Bendtzen K (1989) IL-6 primes human neutrophil and monocyte oxidative burst response. Immunol Lett 21:177–184

    Article  PubMed  CAS  Google Scholar 

  41. Khurihara N, Betrolini D, Suda T et al (1990) IL-6 stimulates osteoclast like multinucleated cell formation in long term human marrow cultures by inducing IL-1 release. J Immunol 144:4226–4230

    Google Scholar 

  42. Kinne WR, Brauer R, Stuhlmuller B et al (2000) Macrophages in rheumatoid arthritis. Arthritis Res 2:189–202

    Article  PubMed  CAS  Google Scholar 

  43. Kitas GD, Erb N (2003) Tackling ischaemic heart disease in rheumatoid arthritis. Rheumatol [Oxf] 42:607–613

    Article  CAS  Google Scholar 

  44. Koota K, Isomaki HA, Mutru O (1977) Death rate and causes of death in rheumatoid arthritis patients during a period of five years. Scand J Rheumatol 6:241–244

    Article  PubMed  CAS  Google Scholar 

  45. Kroot E, de Jong BAW, van Leeuwen MA et al (2000) The prognostic value of the anti-cyclic citrullinated peptide antibody in patients with recent onset rheumatoid arthritis. Arthritis Rheum 43:1831–1835

    Article  PubMed  CAS  Google Scholar 

  46. Li H, Chen J, Huang A et al (2000) Cloning and characterization of IL-17B and IL-17C, two new members of the IL-17 cytokine family. Proc Natl Acad Sci USA 97:773–778

    Article  PubMed  CAS  Google Scholar 

  47. Luukkainen R, Kaarela K, Isomaki H et al (1983) The prediction of radiological destruction during the early stage of rheumatoid arthritis. Clin Exp Rheumatol 1:295–298

    PubMed  CAS  Google Scholar 

  48. Machold KP, Stamm TA, Eberl GJM et al (2002) Very recent onset arthritis-clinical, laboratory and radiological findings during the first year of disease. J Rheumatol 29:2278–2287

    PubMed  Google Scholar 

  49. Macintyre SS, Kushner I, Samols D (1985) Secretion of C-reactive protein becomes more efficient during the course of the acute phase response. J Biol Chem 260:4169–4173

    PubMed  CAS  Google Scholar 

  50. Maeno N, Takei S, Imanaka H et al (2004) Increased interleukin-18 expression in bone marrow of a patient with systemic juvenile idiopathic arthritis and unrecognized macrophage-activation syndrome. Arthritis Rheum 50:1935–1938

    Article  PubMed  Google Scholar 

  51. Masi AT, Aldag JC, Sipes J (2001) Do elevated levels of serum C-reactive protein predict rheumatoid arthritis in men: correlations with pre-RA status and baseline positive rheumatoid factors. J Rheumatol 28:2359–2361

    PubMed  CAS  Google Scholar 

  52. Michael JP, Arnold LW, Margaret MO et al (2000) Relationship between time-integrated C-reactive protein levels and radiologic progression in patients with rheumatoid arthritis. Arthritis Rheum 43(7):1473–1477

    Article  Google Scholar 

  53. Molenaar TH, Voskuyl AE, Familian A et al (2001) Complement activation in patients with rheumatoid arthritis mediated in part by C-reactive protein. Arthritis Rheum 44(5):997–1002

    Article  PubMed  CAS  Google Scholar 

  54. Naka T, Nishimoto N, Kishimoto T (2002) The paradigm of IL-6: from basic science to medicine. Arthritis Res 4(suppl 3):S233–S242

    Article  PubMed  Google Scholar 

  55. Nelson JL, Ostenson M (1997) Pregnancy and rheumatoid arthritis. Rheum Dis Clin N Am 23:195–212

    Article  CAS  Google Scholar 

  56. Nielen MM, van Schaardenburg D, Reesink HW et al (2004) Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors. Arthritis Rheum 50(2):380–386

    Article  PubMed  Google Scholar 

  57. Nielen MM, van Schaardenburg D, Reesink HW et al (2004) Increased levels of C-reactive protein in serum from blood donors before the onset of rheumatoid arthritis. Arthritis Rheum 50(8):2423–2427

    Article  PubMed  CAS  Google Scholar 

  58. Norihiro N, Aie I, Mika O et al (2000) IL-6 inhibits the proliferation of fibroblastic synovial cells from rheumatoid arthritis patients in the presence of soluble IL-6 receptor. Int Immunol 12(02):187–193

    Article  Google Scholar 

  59. Oppmann B, Lesley R, Blom B (2000) Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity 13:715–725

    Article  PubMed  CAS  Google Scholar 

  60. Otterness IG (1994) The value of C-reactive protein measurement in rheumatoid arthritis. Semin Arthritis Rheum 24:91–104

    Article  PubMed  CAS  Google Scholar 

  61. Panayi GS, Corrigall VM, Pitzalis C (2001) Pathogenesis of rheumatoid arthritis. The role of T cells and other beasts. Rheum Dis Clin North Am 27(2):317–334

    Article  PubMed  CAS  Google Scholar 

  62. Paradowska GA, Grzybowska KA, Wojtecka LE, Maslinski S (2010) IL-23 in the pathogenesis of rheumatoid arthritis. Scand J Immunol 71(3):134–145

    Article  CAS  Google Scholar 

  63. Paradowska A, Maślińiski W, Grzybowska-Kowalczyk A, Lacki J (2007) The function of interleukin 17 in the pathogenesis of rheumatoid arthritis. Arch Immunol Ther Exp (Warsz) 55(5):329–334

    Article  CAS  Google Scholar 

  64. Pettit AR, Ji H, von Stechow D et al (2001) TRANCE/RANKL knockout mice are protected from bone erosion in a serum transfer model of arthritis. Am J Pathol 159:1689–1699

    Article  PubMed  CAS  Google Scholar 

  65. Pincus T (2000) Laboratory tests in rheumatic diseases. Rheumatology 2(10):1–8

    Google Scholar 

  66. Proudman SM, Conaghan PG, Richardson C et al (2000) Treatment of poor-prognosis early rheumatoid arthritis. A randomized study of treatment with methotrexate, cyclosporin A, and intraarticular corticosteroids compared with sulfasalazine alone. Arthritis Rheum 43:1809–1819

    Article  PubMed  CAS  Google Scholar 

  67. Raffaele B, Joost J (1996) Role of cytokines, APPs and chemokines in the progression of RA. Arthritis Rheum 26(2):526–538

    Article  Google Scholar 

  68. Raimund WK, Rolf B, Bruno S et al (2000) Macrophages in Rheumatoid arthritis. Arthritis Res 2:189–202

    Article  Google Scholar 

  69. Rajan M, Anne C, John W, Hilary AC (1993) Serum interleukin 6 levels in rheumatoid arthritis: correlations with clinical and laboratory indices of disease activity. Ann Rheum Dis 52:232–234

    Article  Google Scholar 

  70. Rantapaa DS, de Jong BA, Berglin E et al (2003) Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis. Arthritis Rheum 48:2741–2749

    Article  CAS  Google Scholar 

  71. Rantapaa DS, Wallberg JS, Dahlen G (1991) Lipoprotein [a], lipids, and lipoproteins in patients with rheumatoid arthritis. Ann Rheum Dis 50:366–368

    Article  Google Scholar 

  72. Rasker JJ, Cosh JA (1981) Cause and age at death in a prospective study of 100 patients with rheumatoid arthritis. Ann Rheum Dis 40:115–120

    Article  PubMed  CAS  Google Scholar 

  73. Rindfleisch AJ, Muller D (2005) Diagnosis and management of rheumatoid arthritis. Am Fam Physician 72(6):1037–1047

    PubMed  Google Scholar 

  74. Rong C, Hu W, Wu FR et al (2012) Interleukin-23 as a potential therapeutic target for rheumatoid arthritis. Mol Cell Biochem 361(1–2):243–248

    Article  PubMed  CAS  Google Scholar 

  75. Schellekens GA, Visser H, de Jong BA et al (2000) The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide. Arthritis Rheum 43:155–163

    Article  PubMed  CAS  Google Scholar 

  76. Schuerwegha AJM, Ioan-Facsinaya A, Dorjéea AL et al (2010) Evidence for a functional role of IgE anticitrullinated protein antibodies in rheumatoid arthritis. PNAS 107(6):2586–2591

    Article  Google Scholar 

  77. Sherrer YS, Bloch DA, Mitchell DM et al (1986) The development of disability in rheumatoid arthritis. Arthritis Rheum 29:494–500

    Article  PubMed  CAS  Google Scholar 

  78. Sherry B, Cerami A (1988) Cachectin/TNF exerts endocrine, paracrine and autocrine control of inflammatory responses. J Cell Biol 107:1269–1277

    Article  PubMed  CAS  Google Scholar 

  79. Silverman GJ, Carson DA (2003) Roles of B cells in rheumatoid arthritis. Arthritis Res Ther 5(Suppl 4):S1–S6

    Article  PubMed  Google Scholar 

  80. Simon M, Girbal E, Sebbag M et al (1993) The cytokeratin filament-aggregating protein filaggrin is the target of the so-called ‘antikeratin antibodies’, autoantibodies specific for rheumatoid arthritis. J Clin Invest 92:1387–1393

    Article  PubMed  CAS  Google Scholar 

  81. Smolen JS, Steiner G (2003) Therapeutic strategies for rheumatoid arthritis. Nat Rev Drug Discov 2:473–488

    Article  PubMed  CAS  Google Scholar 

  82. Starnes T, Robertson MJ, Sledge G et al (2001) Cutting edge: IL-17F, a novel cytokine selectively expressed in activated T cells and monocytes, regulates angiogenesis and endothelial cell cytokine production. J Immunol 167:4137–4140

    PubMed  CAS  Google Scholar 

  83. Steven KL, Sujata S, Laura AT, David AF (2007) Cells of the synovium in rheumatoid arthritis. T lymphocytes. Arthritis Res Ther 9(1):202

    Article  CAS  Google Scholar 

  84. Surekha HR, Madhavi G, Srikanth BMV et al (2006) Serum ADA and C-reactive protein in rheumatoid arthritis. Int J Hum Genet 6(3):195–198

    Google Scholar 

  85. Tanabe M, Ochi T, Tomita T et al (1994) Remarkable elevation of IL-6 and IL-8 levels in the bone marrow serum of patients with RA. J Rheumatal 21:830–835

    CAS  Google Scholar 

  86. Tarner IH, Muller-Ladner U, Gay RE et al (2003) The pathogenesis of rheumatoid arthritis-gene transfer to detect novel targets for treatment, vol. 354. Frontiers in Autoimmunity IOS Press, Amsterdam. pp. 315–346

  87. Thomas P, Ulf ML, Renate EG, Steffen G (2000) Fibroblast biology, role of synovial fibroblasts in the pathogenesis of rheumatoid arthritis. Arthritis Res 2:361–367

    Article  Google Scholar 

  88. Tineke C, Leen DR, Tim B et al (2006) Citrullinated proteins in rheumatoid arthritis. Arthritis Rheum 54(11):3381–3389

    Article  CAS  Google Scholar 

  89. Vallbracht I, Rieber J, Oppermann M et al (2004) Diagnostic and clinical value of anti-cyclic citrullinated peptide antibodies compared with rheumatoid factor isotypes in rheumatoid arthritis. Ann Rheum Dis 63:1079–1084

    Article  PubMed  CAS  Google Scholar 

  90. van der Heijde DM (1995) Joint erosions and patients with early rheumatoid arthritis. Br J Rheumatol 34(suppl 2):74–78

    PubMed  Google Scholar 

  91. van der Heijde V, Riel DP, Van Rijswijk MH, Van de Putte LB (1988) Influence of prognostic features on the final outcome in RA. Arthritis Rheum 17:282–292

    Google Scholar 

  92. van Gaalen FA, van Aken J, Huizinga TW et al (2004) Association between HLA class II genes and autoantibodies to cyclic citrullinated peptides (CCPs) influences the severity of rheumatoid arthritis. Arthritis Rheum 50:2113–2121

    Article  PubMed  CAS  Google Scholar 

  93. Verma NU, Misra R, Singh RR et al (2002) Serological correlates of inflammation in RA: usefulness of acute phase reactants in monitoring disease activity. J Indian Rheumatol Assoc 10:1–4

    Google Scholar 

  94. Vossenaar ER, Smeets TJ, Kraan MC et al (2004) The presence of citrullinated proteins is not specific for rheumatoid synovial tissue. Arthritis Rheum 50:3485–3494

    Article  PubMed  CAS  Google Scholar 

  95. Waaler E (1940) On the occurrence of a factor in human serum activating the specific agglutination of sheep red corpuscles. Acta Pathol Microbiol Scand 17:172–188

    Article  CAS  Google Scholar 

  96. Weyand CM, Schmidt D, Wagner U, Goronzy JJ (1998) The influence of sex on the phenotype of rheumatoid arthritis. Arthritis Rheum 41:817–822

    Article  PubMed  CAS  Google Scholar 

  97. Wilder RL (1993) Rheumatoid arthritis: epidemiology pathology and pathogenesis. Prim Rheum Dis 10:86–89

    Google Scholar 

  98. William PA, Jean MD (1995) Inhibition of the production and effects of IL-1 and TNF-α in RA. Arthritis Rheum 38:151–160

    Article  Google Scholar 

  99. Williams RO, Paleolog E, Feldmann M (2007) Cytokine inhibitors in rheumatoid arthritis and other autoimmune diseases. Curr Opin Pharmacol 7(4):412–417

    Article  PubMed  CAS  Google Scholar 

  100. Wordsworth BP, Bell JI (1992) The immunogenetics of rheumatoid arthritis. Springer Semin Immunopathal 14:59–78

    CAS  Google Scholar 

  101. Wright V, Amos R (1980) Do drugs change the course of rheumatoid arthritis? Br Med J 280:964–966

    Article  PubMed  CAS  Google Scholar 

  102. Yelin E, Meenan R, Nevitt M, Epstein W (1980) Work disability in rheumatoid arthritis: effects of disease, social, and work factors. Ann Intern Med 93:551–556

    Article  PubMed  CAS  Google Scholar 

  103. Yeong WS, Eun HK (2010) The pathogenic role of rheumatoid factor in rheumatoid arthritis. Int J Clin Rheumatol 5(6):651–658

    Article  Google Scholar 

  104. Yue CC, Muller GJ, Dailey P et al (1996) Identification of a C-reactive protein binding site in two hepatic carboxylesterases capable of retaining C-reactive protein within the endoplasmic reticulum. J Biol Chem 271(36):22245–22250

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Sudha Rustagi College of Dental Sciences and Research, Faridabad, Haryana, India

    Amit Kumar Shrivastava

  2. Narsinhbhai Patel Dental College and Hospital, Vishnagar, Gujarat, India

    Aparna Pandey

Authors
  1. Amit Kumar Shrivastava
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Aparna Pandey
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Amit Kumar Shrivastava.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Shrivastava, A.K., Pandey, A. Inflammation and rheumatoid arthritis. J Physiol Biochem 69, 335–347 (2013). https://doi.org/10.1007/s13105-012-0216-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13105-012-0216-5

Keywords

Search

Navigation